EM2003G "Herpes Zoster and Zoster Vaccines: Neutralizing a Painful Enemy" (IM GR-030620)
Population aging has yielded increasingly large numbers of older persons in the United States and many developed nations. The incidence of herpes zoster and postherpetic neuralgia increases dramatically with aging. The most dreaded complication of herpes zoster in older adults is acute and pain and chronic pain, or postherpetic neuralgia, which has a major negative impact on patients’ quality of life. The purpose and content of this presentation will help learners recognize herpes zoster, know the benefits and risks of the live attenuated and recombinant zoster vaccines to prevent herpes zoster, and better understand remarkable advances in vaccinology that are changing the landscape of vaccine development, efficacy and safety.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Recognize herpes zoster in older adults and its main differential diagnosis
- Elucidate the benefits and limitations of the live attenuated and recombinant zoster vaccines
- Understand advances in vaccine science to protect older adults against vaccine preventable diseases
Kenneth Schmader, M.D.
Professor of Medicine
Director, Pepper Older Americans Independence Center (NIA)
Duke University Medical Center
Director, Geriatric Research Education and Clinical Center (GRECC)
Durham VA Health Care System
The Lorraine Sulkin-Schein Visiting Professor
- 1.00 AMA